Jazz Pharmaceuticals to Present Comprehensive Neuroscience Portfolio at Annual American Academy of Neurology Meeting
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) has revealed that its expansive neuroscience portfolio and pipeline will be prominently featured at the 76th Annual American Academy of Neurology Meeting (AAN), taking place…
Zatolmilast Receives Orphan Medicinal Product Designation from the European Commission: Promising First-in-Class Therapy for Fragile X Syndrome
Shionogi B.V., the European arm of Shionogi & Co., Ltd., has revealed that the European Commission has granted Orphan Medicinal Product designation to zatolmilast (BPN14770), an investigational treatment for Fragile…
Baxter Broadens Pharmaceutical Portfolio with Fresh Injectable Offerings in the U.S.
Baxter International Inc. (NYSE:BAX), renowned globally for its excellence in injectables, anesthesia, and drug compounding, has unveiled a significant expansion of its Pharmaceuticals portfolio with the introduction of five new…
Update: Intangible Asset Impairment, Contingent Consideration Fair Value, FY2023 Financial Forecast Revision
Today, Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) announced an anticipated booking of approximately ¥70.0 billion in the fourth quarter of fiscal year 2023. This booking…
Walgreens Pharmacist Honored as Advocate for Minority Health
As the daughter of immigrants, Gabriela Ziccarelli, PharmD, BCACP, is deeply committed to reducing health disparities, particularly among minority communities. With nearly two decades at Walgreens, she has dedicated much…
Commencement of Novartis’ Tender Offer for MorphoSys AG
Novartis has officially released the offer document for its subsidiary, Novartis BidCo AG’s, voluntary public takeover bid for all outstanding shares of MorphoSys AG, inclusive of MorphoSys American Depositary Shares…
FDA Grants Roche Breakthrough Device Designation for Blood Test Advancing Early Alzheimer’s Disease Detection
Roche (SIX: RO, ROG; OTCQX: RHHBY) disclosed today that its Elecsys pTau217 assay has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). Developed in collaboration…
AbbVie’s New Data Confirms Atogepant (QULIPTA®) for Long-Term Migraine Prevention
AbbVie (NYSE: ABBV) has revealed interim findings from an ongoing Phase 3 extension study, spanning 156 weeks, investigating the sustained safety and tolerability of oral atogepant for migraine prevention in…
Orion Research Assistants Striving to Combat Cancer and Alleviate Pain: “Our Breakthrough Discovery Holds Promise for Shaping Future Research
Mira Leppänen-Mattelmäki, a Research Associate in Orion’s pain team, finds her greatest motivation in the potential impact their work may have on patients. For Minna Vuorenmaa, a Research Assistant in…
Jazz Pharmaceuticals Set to Unveil Broad Range of Neuroscientific Innovations at American Academy of Neurology’s Annual Gathering
Jazz Pharmaceuticals plc (Nasdaq: JAZZ) has revealed that it will present 13 abstracts from its extensive neuroscience portfolio and pipeline at the 76th Annual American Academy of Neurology Meeting (AAN),…
FDA Grants Emergency Use Authorization to Labcorp for Home Collection of Mpox PCR Test
Labcorp (NYSE: LH), a leading provider of innovative laboratory services globally, has announced that the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its Mpox…
Selecting the Ideal Allergy Medication for Your Seasonal Symptoms
For allergy sufferers, the season of congestion, sneezing, watery eyes, scratchy throats, and runny noses has arrived earlier than usual this year. But there’s still time to alleviate those symptoms…